Interferon alpha-2 (IFNα2) increases lacrimal and salivary function in Sjogren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine

Clinical and Experimental Rheumatology

Volumn 14, Issue 4, 1996, Pages 367-371

  Ferraccioli, G F ^a,d   Salaffi, F ^b   De Vita, S ^a   Casatta, L ^a   Avellini, C ^a   Carotti, M ^b   Beltrami, C A ^a,c   Cervini, C ^b,c   Bartoli, E ^a,c  

^a UNIVERSITY OF UDINE   (Italy)

^b School of Medicine of Ancona   (Italy)

^c Department of Internal ^*

^d Section of Oncology and Molecular Pathology   (Italy)

Author keywords

interferon; Sjogren's syndrome

Indexed keywords

HYDROXYCHLOROQUINE; RECOMBINANT ALPHA2 INTERFERON;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENE REARRANGEMENT; HUMAN; KERATOCONJUNCTIVITIS SICCA; LACRIMAL GLAND; LYMPHOID CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALIVARY GLAND FUNCTION; SIALOADENITIS; SJOEGREN SYNDROME; TREATMENT OUTCOME; XEROSTOMIA;

ANTIRHEUMATIC AGENTS; ANTIVIRAL AGENTS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; INTERFERON TYPE I, RECOMBINANT; LACRIMAL APPARATUS; MIDDLE AGED; PILOT PROJECTS; QUESTIONNAIRES; SALIVA; SALIVARY GLANDS; SJOGREN'S SYNDROME; TEARS;

EID: 0030017916     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. FOX RI, CHAN E, BENTON L, FONG S, FRIEDLAENDER M, HOWELL FV: Treatment of Sjögren's syndrome with hydroxychloroquine. Am J Med 1988; 85: 62-6.
2. FOX RI: Treatment of the patient with Sjögren's syndrome. Rheum Dis Clin North Am 1992; 18: 699-709.
3. RUDNICK RD, GRESHAM GE, ROTHFIELD NF: The efficacy of antimalarials in systemic lupus erythematosus. J Rheumatol 1975; 2: 323-5.
4. TERADA K, KATAMINE S, EGUCHI K, MORIUKI R, KITA M, SHIMADA M, YAMASHITA I, IWATA K, TSUJI Y, NAGATAKI S, MIYAMOTO T: Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet 1994; 344: 1116-9.
5. DE CLERK LS, BOURGEOIS N, KRUEGER GRF, STEVENS WJ: Human herpes virus 6 in Sjögren's syndrome. In: ABLASHI, KRUEGER, SALAFUDDIN (Eds.): Human HerpesVirus 6, Elsevier Science Publishers B.V., 1992; 303-15.
6. DE VITA S, FERRACCIOLI GF, DE RE V, DOLCETTI R, CARBONE A, BARTOLI E, MARZOTTO A, PIVETTA B, BOIOCCHI M: Polymerase chain reaction detects B cell clonality in patients with Sjögren's syndrome and suspected malignant lymphoma. J Rheumatol 1994; 21: 1497-501.
7. SHENOY M, BARON S, WU B, GOLUSZKO E, CHRISTADOSS P: IFNa treatment suppresses the development of experimental autoimmune myasthenia gravis. J Immunol 1995; 154: 6203-8.
8. VITALI C, BOMBARDIERI S, MOUTSOPOULOS H, et al.: Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 1993; 36: 315-24.
9. WITTER CP, CATOVSKY D, CAWLEY JC, BEVAN PC, BOTTOMLEY JM: Effects of prednisone, aspirin, and acetaminophen on an in vivo biologic response to interferon in human. Clin Pharmacol Therapeutics 1988; 44: 239-43.
10. ATKINSON JC: The role of salivary measurements in the diagnosis of salivary autoimmune diseases. Ann NY Acad Sci 1993; 694: 238-51.
11. FOX P, VADERVEN PF, BAUM BJ: Pilocarpine for the treatment of xerostomia associated with salivary gland disfunction. Oral Surg Oral Med Oral Pathol 1986; 51: 243-6.
12. WORKSHOP ON DIAGNOSTIC CRITERIA FOR SJÖGREN'S SYNDROME: I: Questionnaires for dry eye and dry mouth. II. Manual of methods and procedures. Clin Exp Rheumatol 1989; 7: 212-9.
13. KOHLER PF, WINTER ME: A quantitative test for xerostomia: the Saxon test, an oral equivalent of the Schirmer's test. Arthritis Rheum 1985; 28: 1128-32.
14. SNEDECOR GW, COCHRANE WG: Statistical Methods. 7th Ed. Ames, Iowa, USA. The Iowa State University Press, 1980; 255-69.
15. CHISHOLM DM, MASON DK: Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968; 21: 656-60.
16. SHIOZAWA S, MORIMOTO I, TANAKA Y, SHIOZAWA K: A preliminary study on the interferon-alpha treatment for xerostomia of Sjögren's syndrome. Br J Rheumatol 1993; 32: 52-4.
17. JONSSON R, KRONELD U, BACHMAN K, MAGNUSSON B, TARKOWSKI A: Progression of sialadenitis in Sjögren's syndrome. Br J Rheumatol 1993; 32: 578-81.
18. KRUIZE AA, HENE' RJ, KALLENBERG CGM, VAN BIJSTERVELD OP, VAN DER HEIDE A, KATER L, BIJLSMA JW: Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 1993; 52: 360-4.
19. ANDERSON LG, CUMMINGS NA, ASOFSKY R: Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med 1972; 53: 456-63.
20. KASSAN SS, THOMAS TL, MOUTSOPOULOS HM, HOOVER R, KIMBERLY RP, BUDMAN DR, COSTA J, DECKER JL, CHUSED TM: Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89: 888-92.
21. SHIOZAWA S, SHIOZAWA K, SHIMIZU S, TANAKA Y, MORIMOTO I, YOSHIHARA R, KUROKI Y, HASHIMOTO M, FUJITA T: Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome. Br J Rheumatol 1990; 29: 50-2.
22. PESCHEL C, AMAN MJ, RUDOLF G, AULITZKY WE, HUBER C: Regulation of the cytokine network by interferon: a potential mechanism of interferon in chronic myelogenous leukemia. Semin Hematol 1993; 30: 28-31.
23. KONTTINEN Y, HUKKANEN M, SEGERBERG M: Neuropeptide nerves inplicated in the pathogenesis of Sjögren's syndrome. Clin Exp Rheumatol 1991; 9: 319.